$7.41 B
Share price
Change (1 day)
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: $7.41 Billion

As of December 2022 Sinopharm has a market cap of $7.41 Billion. This makes Sinopharm the world's 1799th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2022

End of year Market Cap

Year Market cap Change
2022$7.41 B9.2%
2021$6.78 B-5.92%
2020$7.21 B-33.54%
2019$10.85 B-13.05%
2018$12.48 B4.34%
2017$11.96 B4.95%
2016$11.40 B2.68%
2015$11.10 B13.38%
2014$9.79 B32.88%
2013$7.36 B-1.96%
2012$7.51 B30.31%
2011$5.76 B-26.85%
2010$7.88 B-1.99%
2009$8.04 B

End of Day market cap according to different sources

On Dec 4th, 2022 the market cap of Sinopharm was reported to be:

$3.13 Billion
by Iex Cloud
$7.29 Billion
by CompaniesMarketCap